BIOCRYST PHARMACEUTICALS, INC. (BCRX) Capital expenditures 2017–2019
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$343,000FY2019 · since FY2017: $328,000 → $343,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $343,000 | -6.3% |
| FY2018 | $366,000 | +11.6% |
| FY2017 | $328,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice